CTKB Cytek Biosciences, Inc. - Common Stock
NASDAQ · Life Sciences Tools & Services · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 5, 2026
$5.87
· % 处于52周区间
· 高于低点
· 至高点
$3.3152周低点
$6.1852周高点
市值 (MRQ)
$763M
P/E
587.0
EPS
$-0.09
收入
$201M
CTKB 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$5.87
市值 (MRQ)
$763M
P/E
587.0
EPS
$-0.09
收入
$201M
ROE
-18.5%
52周区间
$3–$6
CTKB 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$201M2020-12-31 → 2025-12-31
EPS$-0.092020-12-31 → 2023-12-31
自由现金流$-9M2021-12-31 → 2025-12-31
净利率-39.0%2021-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | CTKB | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E | 587.05年均值 ≈390.8 | ≈390.8 | · | · | |
| P/S (TTM) | 3.75年均值 ≈204.6 | ≈204.6 | 3.8 | 低估 | |
| 市净率 (MRQ) | 2.45年均值 ≈3.1 | ≈3.1 | 3.0 | 低估 | |
| 股价/自由现金流 (TTM) | -63.25年均值 ≈1998.1 | ≈1998.1 | · | · | |
| 市现率 (TTM) | -126.45年均值 ≈95.7 | ≈95.7 | · | · | |
| 市净率（有形资产） (MRQ) | 2.55年均值 ≈3.4 | ≈3.4 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | CTKB | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 毛利率 (TTM) | 53.2%5年均值 ≈57.5% | ≈57.5% | 45.8% | 顶尖 | |
| 营业利润率 (TTM) | -21.6%5年均值 ≈-7.7% | ≈-7.7% | -22.1% | 持平 | |
| 息税折旧摊销前利润率 (TTM) | -17.9%5年均值 ≈-5.1% | ≈-5.1% | -22.1% | 持平 | |
| Pretax Margin (税前利润率) | -14.8%5年均值 ≈-4.1% | ≈-4.1% | -15.3% | 持平 | |
| 净利润率 (TTM) | -39.0%5年均值 ≈-7.7% | ≈-7.7% | -21.1% | 低于平均水平 | |
| ROA | -13.9%5年均值 ≈-3.2% | ≈-3.2% | -14.7% | 持平 | |
| ROE | -18.5%5年均值 ≈-4.3% | ≈-4.3% | -21.2% | 持平 | |
| ROIC | -26.4%5年均值 ≈-7.4% | ≈-7.4% | -25.6% | 持平 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | CTKB | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 4.55年均值 ≈8.0 | ≈8.0 | 3.5 | 流动性强 | |
| Quick Ratio (速动比率) | 2.05年均值 ≈5.4 | ≈5.4 | 1.4 | 持平 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | CTKB | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 0.52%5年均值 ≈1530.1% | ≈1530.1% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 7.1%5年均值 ≈302.1% | ≈302.1% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 209.5% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | CTKB | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.45年均值 ≈0.4 | ≈0.4 | 0.3 | 顶尖 | |
| Inventory Turnover (库存周转率) | 2.15年均值 ≈1.7 | ≈1.7 | 3.7 | 弱 | |
| Receivables Turnover (应收账款周转率) | 3.35年均值 ≈4.0 | ≈4.0 | 5.7 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$295.4K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-27.9%
下次报告
十一月 03, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 12, 2026 | $-0.08 | $-0.09 | 7.7% |
| 2026年3月31日 | 五月 13, 2026 | $-0.15 | $-0.10 | -52.1% |
| 2025年12月31日 | $-0.04 | $-0.02 | -96.1% | |
| 2025年9月30日 | $-0.04 | $-0.05 | 25.4% | |
| 2025年6月30日 | $-0.04 | $-0.07 | 44.0% | |
| 2025年3月31日 | $-0.09 | $-0.05 | -96.1% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $201M | $200M | $193M | $164M | $2M | $710.0K | |
| Cost of Revenue | $97M | $89M | $84M | $63M | $49M | $41M | |
| Gross Profit | $104M | $111M | $109M | $101M | $79M | $52M | |
| R&D Expense | $36M | $39M | $44M | $35M | $24M | $14M | |
| SG&A Expense | $59M | $43M | $44M | $35M | $21M | $9M | |
| Operating Expenses | $145M | $132M | $137M | $103M | $70M | $38M | |
| Operating Income | $-40M | $-21M | $-28M | $-2M | $9M | $14M | |
| Interest Expense | · | · | $2M | $3M | $2M | $333.0K | |
| Interest Income | $2M | $5M | $6M | $5M | $49.0K | $110.0K | |
| Other Non-op | $9M | $4M | $8M | $1M | $-2M | $994.0K | |
| Pretax Income | $-30M | $-6M | $-16M | $1M | $6M | $14M | |
| Income Tax | $37M | $320.0K | $-4M | $-1M | $3M | $-5M | |
| Net Income | $-67M | $-6M | $-12M | $2M | $3M | $19M | |
| EPS (Basic) | · | · | $-0.09 | $0.02 | $0.00 | $0.11 | |
| EPS (Diluted) | · | · | $-0.09 | $0.02 | $0.00 | $0.10 | |
| Shares (Basic) | 127,745,939 | 130,611,330 | 135,283,044 | 134,510,831 | 76,741,858 | 29,126,792 | |
| Shares (Diluted) | 127,745,939 | 130,611,330 | 135,283,044 | 138,562,111 | 81,542,729 | 32,599,847 | |
| EBITDA | $-33M | $-13M | $-22M | $688.0K | $10M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $91M | $99M | $167M | $297M | $365M | $165M | |
| Receivables | $63M | $61M | $56M | $49M | $30M | $17M | |
| Inventory | $48M | $44M | $61M | $48M | $32M | $23M | |
| Prepaid Expense | $20M | $14M | $13M | $13M | $5M | $2M | |
| Other Current Assets | $3M | $2M | $2M | $4M | $708.0K | $445.0K | |
| Current Assets | $392M | $396M | $392M | $454M | $432M | $209M | |
| PP&E (Net) | $18M | $18M | $18M | $14M | $6M | $2M | |
| PP&E (Gross) | $30M | $27M | $24M | $17M | $8M | $3M | |
| Accum. Depreciation | $12M | $9M | $6M | $3M | $2M | $934.0K | |
| Goodwill | $17M | $17M | $16M | $10M | $10M | $476.0K | |
| Intangibles | $17M | $20M | $23M | $4M | $5M | $274.0K | |
| Other Non-current Assets | $7M | $5M | $3M | $3M | $2M | $1M | |
| Total Assets | $462M | $500M | $494M | $519M | $463M | $220M | |
| Accounts Payable | $23M | $21M | $20M | $21M | $15M | $9M | |
| Accrued Liabilities | $23M | $21M | $20M | $21M | $15M | $9M | |
| Current Liabilities | $78M | $68M | $56M | $49M | $33M | $27M | |
| Capital Leases | $14M | $8M | $9M | $12M | $0 | · | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $1M | $737.0K | |
| Total Liabilities | $120M | $104M | $101M | $94M | $58M | $42M | |
| Common Stock | $129.0K | $129.0K | $131.0K | $135.0K | $126.0K | $23.0K | |
| Paid-in Capital | $441M | $431M | $423M | $443M | $424M | $6M | |
| Retained Earnings | $-102M | $-35M | $-29M | $-17M | $-20M | $-23M | |
| AOCI | $2M | $16.0K | $-1M | $-697.0K | $897.0K | $65.0K | |
| Stockholders' Equity | $342M | $396M | $393M | $426M | $405M | $-16M | |
| Liabilities + Equity | $462M | $500M | $494M | $519M | $463M | $220M | |
| Shares Outstanding | 128,550,136 | 129,205,901 | 130,714,906 | 135,365,381 | 133,749,663 | 31,241,916 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $8M | $7M | $6M | $2M | $1M | $603.0K | |
| Stock-based Comp | $25M | $27M | $22M | $17M | $7M | $611.0K | |
| Deferred Tax | $34M | $-3M | $0 | $0 | $-2M | $-7M | |
| Amort. of Intangibles | $4M | $4M | $3M | $800.0K | $300.0K | $71.0K | |
| Other Non-cash | $-4M | $225.0K | $-638.0K | $-23M | $-4M | · | |
| Operating Cash Flow | $-5M | $25M | $5M | $-12M | $5M | $15M | |
| CapEx | $4M | $4M | $5M | $10M | $4M | $2M | |
| Investing Cash Flow | $10M | $-83M | $-94M | $-56M | $-21M | $-2M | |
| Stock Repurchased | $15M | $22M | $44M | $0 | $0 | · | |
| Net Stock Activity | $-15M | $-22M | $-44M | · | · | · | |
| Financing Cash Flow | $-13M | $-16M | $-42M | $6M | $214M | $123M | |
| Net Change in Cash | $-8M | $-69M | $-132M | $-65M | $198M | $136M | |
| Taxes Paid | $2M | $4M | $5M | $10M | $3M | $2M | |
| Free Cash Flow | $-9M | $22M | $633.0K | $-22M | $266.0K | · | |
| Levered FCF | · | · | $-968.5K | $-27M | $-621.5K | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 51.8% | 55.4% | 56.7% | 61.6% | 61.9% | · | |
| Operating Margin | -20.0% | -10.2% | -14.4% | -1.1% | 7.2% | · | |
| Net Margin | -33.0% | -3.0% | -6.3% | 1.5% | 2.4% | · | |
| Pretax Margin | -14.8% | -2.8% | -8.1% | 0.77% | 4.6% | · | |
| EBITDA Margin | -16.3% | -6.6% | -11.3% | 0.42% | 8.1% | · | |
| ROA | -13.9% | -1.2% | -2.4% | 0.51% | 0.89% | · | |
| ROE | -18.5% | -1.5% | -3.0% | 0.59% | 0.75% | · | |
| ROIC | -26.4% | -5.5% | -5.5% | -0.84% | 1.1% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 5.9 | 7.0 | 9.3 | 13.0 | · | |
| Quick Ratio | 2.0 | 2.4 | 4.0 | 7.0 | 11.9 | · | |
| Interest Coverage | · | · | -13.4 | -0.7 | 5.3 | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.4 | 0.3 | 0.4 | · | |
| Inventory Turnover | 2.1 | 1.7 | 1.5 | 1.6 | 1.8 | · | |
| Receivables Turnover | 3.3 | 3.4 | 3.7 | 4.2 | 5.5 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.66 | $3.06 | $3.01 | $3.14 | $3.03 | · | |
| Revenue / Share | $1.58 | $1.53 | $1.43 | $1.18 | $1.57 | · | |
| Cash Flow / Share | $-0.04 | $0.19 | $0.04 | $-0.09 | $0.06 | · | |
| Cash / Share | $0.71 | $0.76 | $1.28 | $2.19 | $2.73 | · | |
| EPS (TTM) | $0.01 | $0.01 | $-0.09 | $0.02 | $0.00 | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 0.52% | 3.9% | 17.7% | 7421.1% | 207.2% | · | |
| Revenue CAGR 3Y | 7.1% | 351.3% | 547.8% | · | · | · | |
| Revenue CAGR 5Y | 209.5% | · | · | · | · | · | |
| Net Income YoY | · | · | · | -17.9% | -84.4% | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $201M | $200M | $193M | $164M | $2M | · | |
| Net Income TTM | $-67M | $-6M | $-12M | $2M | $3M | · | |
| Market Cap | $649M | $839M | $1.19B | $1.38B | $2.18B | · | |
| P/E | 505.0 | 649.0 | -101.3 | 510.5 | · | · | |
| P/S | 3.2 | 4.2 | 6.2 | 8.4 | 1000.8 | · | |
| P/B | 1.9 | 2.1 | 3.0 | 3.2 | 5.4 | · | |
| P / Tangible Book | 2.1 | 2.3 | 3.4 | 3.4 | 5.6 | · | |
| P / Cash Flow | -138.5 | 33.0 | 225.7 | -113.0 | 471.4 | · | |
| P / FCF | -74.0 | 38.4 | 1883.3 | -62.9 | 8206.0 | · | |
| Earnings Yield | 0.20% | 0.15% | -0.99% | 0.20% | 0.00% | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $48M | $44M | $62M | $52M | $46M | $41M | $57M | $52M | $47M | $45M | $58M | $48M | $50M | $37M | $48M | $40M | |
| Cost of Revenue | $20M | $23M | $29M | $25M | $22M | $21M | $24M | $22M | $21M | $22M | $25M | $21M | $22M | $16M | $19M | $14M | |
| Gross Profit | $28M | $21M | $33M | $28M | $24M | $20M | $34M | $29M | $25M | $23M | $33M | $27M | $28M | $21M | $29M | $27M | |
| R&D Expense | $10M | $10M | $9M | $9M | $9M | $10M | $10M | $10M | $10M | $10M | $11M | $11M | $12M | $10M | $10M | $9M | |
| SG&A Expense | $17M | $18M | $16M | $16M | $14M | $13M | $9M | $11M | $12M | $11M | $11M | $10M | $11M | $12M | $11M | $8M | |
| Operating Expenses | $40M | $40M | $38M | $37M | $34M | $35M | $31M | $33M | $34M | $34M | $33M | $34M | $37M | $33M | $29M | $26M | |
| Operating Income | $-11M | $-18M | $-6M | $-9M | $-11M | $-15M | $3M | $-4M | $-9M | $-11M | $-136.0K | $-6M | $-9M | $-12M | $84.0K | $1M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $441.0K | · | $595.0K | $409.0K | $673.0K | · | $649.0K | |
| Interest Income | $819.0K | $787.0K | $580.0K | $573.0K | $555.0K | $508.0K | $913.0K | $1M | $1M | $1M | $1M | $2M | $1M | $2M | $3M | $2M | |
| Other Non-op | $-781.0K | $565.0K | $257.0K | $1M | $4M | $3M | $490.0K | $3M | $59.0K | $823.0K | $3M | $1M | $2M | $2M | $2M | $-445.0K | |
| Pretax Income | · | · | $-4M | $-8M | $-7M | $-11M | $10M | $157.0K | $-7M | $-9M | $4M | $-4M | $-7M | $-9M | $4M | $2M | |
| Income Tax | $515.0K | $1M | $40M | $-2M | $-1M | $136.0K | $680.0K | $-784.0K | $3M | $-3M | $-1M | $2M | $-2M | $-2M | $396.0K | $224.0K | |
| Net Income | $-12M | $-19M | $-44M | $-5M | $-6M | $-11M | $10M | $941.0K | $-10M | $-6M | $6M | $-6M | $-4M | $-7M | $4M | $2M | |
| EPS (Basic) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-0.01 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-0.01 | |
| Shares (Basic) | 129,460,518 | 128,704,934 | · | 127,547,859 | 126,934,294 | 128,339,481 | · | 131,003,744 | 131,440,486 | 130,920,971 | · | 136,173,278 | 135,918,707 | 135,489,194 | · | 134,711,701 | |
| Shares (Diluted) | 129,460,518 | 128,704,934 | · | 127,547,859 | 126,934,294 | 128,339,481 | · | 132,785,552 | 131,440,486 | 130,920,971 | · | 136,173,278 | 135,918,707 | 135,489,194 | · | 138,709,335 | |
| EBITDA | $-11M | $-17M | · | $-9M | $-11M | $-13M | · | $-4M | $-9M | $-9M | · | $-6M | $-9M | $-11M | · | $1M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $74M | $66M | $91M | $93M | $75M | $95M | $99M | $162M | $178M | $169M | · | $164M | $132M | $129M | · | $342M | |
| Receivables | $50M | $52M | $63M | $57M | $56M | $55M | $61M | $53M | $45M | $50M | · | $55M | $50M | $43M | · | $40M | |
| Inventory | $52M | $50M | $48M | $52M | $49M | $45M | $44M | $47M | $50M | $55M | · | $67M | $66M | $70M | · | $49M | |
| Prepaid Expense | $14M | $15M | $20M | $18M | $15M | $15M | $14M | $13M | $12M | $13M | · | $12M | $11M | $11M | · | $13M | |
| Other Current Assets | $5M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $1M | · | $2M | |
| Current Assets | $378M | $379M | $392M | $388M | $383M | $381M | $396M | $390M | $384M | $389M | · | $422M | $425M | $426M | · | $444M | |
| PP&E (Net) | $21M | $20M | $18M | $18M | $18M | $18M | $18M | $19M | $18M | $18M | · | $17M | $16M | $16M | · | $8M | |
| PP&E (Gross) | $35M | $34M | $30M | $30M | $29M | $27M | $27M | $27M | $25M | $24M | · | $22M | $20M | $19M | · | $10M | |
| Accum. Depreciation | $14M | $13M | $12M | $12M | $11M | $10M | $9M | $8M | $7M | $6M | · | $5M | $4M | $4M | · | $3M | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $16M | $16M | $16M | · | $16M | $19M | $19M | · | $10M | |
| Intangibles | $15M | $16M | $17M | $18M | $19M | $19M | $20M | $20M | $21M | $22M | · | $24M | $24M | $25M | · | $4M | |
| Other Non-current Assets | $6M | $6M | $7M | $4M | $5M | $5M | $5M | $5M | $5M | $4M | · | $3M | $3M | $3M | · | $5M | |
| Total Assets | $447M | $449M | $462M | $495M | $493M | $483M | $500M | $491M | $484M | $492M | · | $519M | $525M | $525M | · | $499M | |
| Accounts Payable | $24M | $20M | $23M | $20M | $22M | $19M | $21M | $21M | $15M | $18M | · | $21M | $20M | $20M | · | $17M | |
| Accrued Liabilities | $24M | $20M | $23M | $20M | $22M | $19M | $21M | $21M | $15M | $18M | · | $21M | $20M | $20M | · | $17M | |
| Current Liabilities | $84M | $81M | $78M | $75M | $73M | $68M | $68M | $63M | $52M | $56M | · | $59M | $54M | $57M | · | $41M | |
| Capital Leases | $14M | $13M | $14M | $13M | $14M | $7M | $8M | $8M | $8M | $9M | · | $10M | $11M | $12M | · | $14M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $1M | |
| Total Liabilities | $125M | $121M | $120M | $116M | $116M | $103M | $104M | $106M | $95M | $99M | · | $104M | $101M | $101M | · | $83M | |
| Common Stock | $130.0K | $129.0K | $129.0K | $128.0K | $127.0K | $128.0K | $129.0K | $130.0K | $132.0K | $131.0K | · | $136.0K | $136.0K | $136.0K | · | $135.0K | |
| Paid-in Capital | $452M | $446M | $441M | $435M | $430M | $427M | $431M | $430M | $435M | $429M | · | $452M | $454M | $448M | · | $437M | |
| Retained Earnings | $-133M | $-121M | $-102M | $-58M | $-52M | $-47M | $-35M | $-45M | $-46M | $-35M | · | $-35M | $-28M | $-24M | · | $-21M | |
| AOCI | $3M | $2M | $2M | $821.0K | $-38.0K | $-609.0K | $16.0K | $101.0K | $-195.0K | $-2M | · | $-2M | $-2M | $-587.0K | · | $-530.0K | |
| Stockholders' Equity | $322M | $328M | $342M | $379M | $378M | $380M | $396M | $385M | $389M | $393M | · | $416M | $424M | $423M | $426M | $417M | |
| Liabilities + Equity | $447M | $449M | $462M | $495M | $493M | $483M | $500M | $491M | $484M | $492M | · | $519M | $525M | $525M | · | $499M | |
| Shares Outstanding | 129,982,753 | 129,142,587 | 128,550,136 | 127,864,830 | 127,185,113 | 127,599,142 | 129,205,901 | 129,766,011 | 131,505,201 | 131,254,181 | · | 135,545,663 | 136,344,908 | 135,644,055 | · | 134,849,139 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $761.0K | $72.0K | |
| Stock-based Comp | $5M | $5M | $6M | $6M | $7M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $5M | $4M | $4M | |
| Deferred Tax | $0 | $-183.0K | $39M | $-3M | $-2M | $-336.0K | $-3M | $0 | $0 | $0 | · | · | · | · | · | · | |
| Amort. of Intangibles | $900.0K | $900.0K | $1M | $900.0K | $900.0K | $900.0K | $1M | $900.0K | $900.0K | $900.0K | $800.0K | $900.0K | $1M | $500.0K | $-353.0K | $200.0K | |
| Other Non-cash | · | $10M | · | · | · | $3M | · | · | · | $3M | · | · | · | $4M | · | · | |
| Operating Cash Flow | $1M | $-3M | $-771.0K | $-4M | $108.0K | $-125.0K | $2M | $13M | $6M | $4M | $10M | $-4M | $-3M | $3M | $6M | $-8M | |
| CapEx | $2M | $2M | $1M | $657.0K | $2M | $849.0K | $894.0K | $1M | $1M | $567.0K | $2M | $1M | $1M | $505.0K | $7M | $1M | |
| Investing Cash Flow | $7M | $-27M | $-2M | $19M | $-16M | $9M | $-63M | $-16M | $2M | $-6M | $29M | $43M | $3M | $-169M | $-51M | $-1M | |
| Stock Repurchased | $0 | $0 | $-34.0K | $-29.0K | $5M | $11M | $7M | $12M | $3M | $0 | $35M | · | · | · | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $-11M | · | $-12M | $-3M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-814.0K | $4M | $-1M | $2M | $-3M | $-12M | $-4M | $-12M | $-2M | $2M | $-34M | $-8M | $216.0K | $0 | $4M | $155.0K | |
| Net Change in Cash | $8M | $-25M | $-2M | $18M | $-20M | $-3M | $-64M | $-16M | $9M | $2M | $4M | $32M | $-850.0K | $-167M | $-42M | $-8M | |
| Taxes Paid | $610.0K | $-4M | $2M | $0 | $25.0K | $0 | $2M | $864.0K | $1M | $0 | $4M | $127.0K | $590.0K | $93.0K | $460.0K | $2M | |
| Free Cash Flow | · | $-5M | · | · | · | $-974.0K | · | · | · | $3M | · | · | · | $2M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $3M | · | · | · | $2M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 58.9% | 48.2% | · | 52.7% | 52.3% | 48.6% | · | 56.3% | 54.6% | 51.3% | · | 56.6% | 56.7% | 56.7% | · | 66.4% | |
| Operating Margin | -23.7% | -41.8% | · | -17.6% | -23.3% | -36.1% | · | -8.2% | -18.3% | -23.9% | · | -13.4% | -18.4% | -32.8% | · | 3.4% | |
| Net Margin | -25.3% | -42.8% | · | -10.5% | -12.2% | -27.5% | · | 1.8% | -22.4% | -13.8% | · | -13.5% | -8.8% | -18.4% | · | 4.0% | |
| Pretax Margin | · | · | · | -14.9% | -14.9% | -27.2% | · | 0.30% | -15.4% | -20.1% | · | -8.7% | -13.3% | -24.4% | · | 4.6% | |
| EBITDA Margin | -23.7% | -37.6% | · | -17.6% | -23.3% | -31.6% | · | -8.2% | -18.3% | -20.1% | · | -13.4% | -18.4% | -30.1% | · | 3.4% | |
| ROA | -2.6% | -4.0% | · | -1.1% | -1.1% | -2.3% | · | 0.19% | -2.1% | -1.2% | · | -1.3% | -0.86% | -1.4% | · | 0.34% | |
| ROE | -3.5% | -5.3% | · | -1.4% | -1.5% | -2.9% | · | 0.23% | -2.6% | -1.5% | · | -1.6% | -1.1% | -1.6% | · | 0.40% | |
| ROIC | · | · | · | -1.7% | -2.3% | -4.0% | · | -6.6% | -3.2% | -1.9% | · | -2.4% | -1.4% | -2.2% | · | 0.29% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 4.7 | · | 5.2 | 5.2 | 5.6 | · | 6.2 | 7.3 | 7.0 | · | 7.2 | 7.9 | 7.5 | · | 10.7 | |
| Quick Ratio | 1.5 | 1.5 | · | 2.0 | 1.8 | 2.2 | · | 3.4 | 4.2 | 3.9 | · | 3.7 | 3.4 | 3.1 | · | 9.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -24.3 | · | -10.8 | -22.3 | -18.1 | · | 2.1 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.4 | 0.5 | · | 0.5 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.3 | · | 0.4 | |
| Receivables Turnover | 0.9 | 0.8 | · | 1.0 | 0.9 | 0.8 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.1 | 1.0 | · | 1.2 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.48 | $2.54 | · | $2.96 | $2.97 | $2.98 | · | $2.97 | $2.96 | $2.99 | · | $3.07 | $3.11 | $3.12 | · | $3.09 | |
| Revenue / Share | $0.37 | $0.34 | · | $0.41 | $0.36 | $0.32 | · | $0.39 | $0.35 | $0.34 | · | $0.35 | $0.37 | $0.27 | · | $0.29 | |
| Cash Flow / Share | · | $-0.02 | · | · | · | $-0.00 | · | · | · | $0.03 | · | · | · | $0.02 | · | · | |
| Cash / Share | $0.57 | $0.51 | · | $0.73 | $0.59 | $0.75 | · | $1.25 | $1.35 | $1.29 | · | $1.21 | $0.96 | $0.95 | · | $2.53 | |
| EPS (TTM) | $0.01 | $0.01 | · | $0.01 | $0.01 | $0.01 | · | $0.01 | $0.01 | $0.01 | · | $0.01 | $0.01 | $0.01 | · | $0.01 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $207M | $204M | · | $197M | $196M | $197M | · | $201M | $198M | $201M | · | $183M | $176M | $166M | · | $29M | |
| Net Income TTM | $-81M | $-74M | · | $-13M | $-6M | $-11M | · | $-10M | $-18M | $-12M | · | $-14M | $-6M | $-2M | · | $-2M | |
| Market Cap | $576M | $564M | · | $444M | $432M | $512M | · | $719M | $734M | $881M | · | $748M | $1.16B | $1.25B | · | $1.98B | |
| P/E | 443.0 | 437.0 | · | 347.0 | 340.0 | 401.0 | · | 554.0 | 558.0 | 671.0 | · | 552.0 | 854.0 | 919.0 | · | 1472.0 | |
| P/S | 2.8 | 2.8 | · | 2.3 | 2.2 | 2.6 | · | 3.6 | 3.7 | 4.4 | · | 4.1 | 6.6 | 7.5 | · | 68.9 | |
| P/B | 1.8 | 1.7 | · | 1.2 | 1.1 | 1.3 | · | 1.9 | 1.9 | 2.2 | · | 1.8 | 2.7 | 2.9 | · | 4.8 | |
| P / Tangible Book | 2.0 | 1.9 | · | 1.3 | 1.3 | 1.5 | · | 2.1 | 2.1 | 2.5 | · | 2.0 | 3.1 | 3.3 | · | 4.9 | |
| P / Cash Flow | · | -206.3 | · | · | · | -4093.4 | · | · | · | 222.6 | · | · | · | 436.2 | · | · | |
| Earnings Yield | 0.23% | 0.23% | · | 0.29% | 0.29% | 0.25% | · | 0.18% | 0.18% | 0.15% | · | 0.18% | 0.12% | 0.11% | · | 0.07% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $201M | $200M | $193M | $164M | $2M |
| 毛利率 % | 51.8% | 55.4% | 56.7% | 61.6% | 61.9% |
| 营业利润率 % | -20.0% | -10.2% | -14.4% | -1.1% | 7.2% |
| 净收入 | $-67M | $-6M | $-12M | $2M | $3M |
| 稀释后每股收益 (EPS) | · | · | $-0.09 | $0.02 | $0.00 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 5.0 | 5.9 | 7.0 | 9.3 | 13.0 |
| 速动比率 | 2.0 | 2.4 | 4.0 | 7.0 | 11.9 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-9M | $22M | $633.0K | $-22M | $266.0K |
机构持有人 (13F) 160 家申报者 · $388.1M 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
160
持有价值
$388.1M
新仓位
30
已退出持仓
38
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 30 (+3 与上一季度对比) | 38 (+27 与上一季度对比) | 45 (-21 与上一季度对比) | 63 (+14 与上一季度对比) | -3.0M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| BlackRock, Inc. | $42433388 | 9578643 | 10.93% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $41367384 | 9338010 | 10.66% | 股份 |
| VANGUARD GROUP INC | $37751160 | 7475477 | 9.73% | 股份 |
| Boston Partners | $33942877 | 7660943 | 8.75% | 股份 |
| HHLR ADVISORS, LTD. | $29490643 | 6657030 | 7.60% | 股份 |
| Topline Capital Management, LLC | $27835684 | 6283450 | 7.17% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $21882415 | 4939597 | 5.64% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $13557155 | 3059573 | 3.49% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $11589081 | 2616257 | 2.99% | 股份 |
| STATE STREET CORP | $11367916 | 2566121 | 2.93% | 股份 |
| GOLDMAN SACHS GROUP INC | $9602092 | 2167515 | 2.47% | 股份 |
| ROYCE & ASSOCIATES LP | $9221395 | 2081579 | 2.38% | 股份 |
| Russell Investments Group, Ltd. | $6695120 | 1511315 | 1.73% | 股份 |
| BANK OF AMERICA CORP /DE/ | $5826921 | 1315332 | 1.50% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $5057253 | 1141592 | 1.30% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4754511 | 1073253 | 1.23% | 股份 |
| NORTHERN TRUST CORP | $4444592 | 1003294 | 1.15% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $4314080 | 973833 | 1.11% | 股份 |
| JANE STREET GROUP, LLC | $4014298 | 906162 | 1.03% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $3711955 | 837913 | 0.96% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $3605891 | 813971 | 0.93% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $3281133 | 740662 | 0.85% | 股份 |
| CITADEL ADVISORS LLC | $3196112 | 721470 | 0.82% | 股份 |
| MORGAN STANLEY | $3108937 | 701792 | 0.80% | 股份 |
| Qube Research & Technologies Ltd | $3055907 | 689821 | 0.79% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3019953 | 681705 | 0.78% | 股份 |
| D. E. Shaw & Co., Inc. | $2964476 | 669182 | 0.76% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $2929559 | 661300 | 0.75% | 股份 |
| FMR LLC | $2234426 | 504385 | 0.58% | 股份 |
| MARSHALL WACE, LLP | $1956749 | 441704 | 0.50% | 股份 |
| Point72 Asset Management, L.P. | $1871059 | 422361 | 0.48% | 股份 |
| Jain Global LLC | $1822790 | 411465 | 0.47% | 股份 |
| Bank of New York Mellon Corp | $1645422 | 371427 | 0.42% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $1294016 | 292103 | 0.33% | 股份 |
| Nuveen, LLC | $1282109 | 289415 | 0.33% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $1182535 | 266938 | 0.30% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1070204 | 241581 | 0.28% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $952494 | 215010 | 0.25% | 股份 |
| Y-Intercept (Hong Kong) Ltd | $855557 | 193128 | 0.22% | 股份 |
| Invesco Ltd. | $822522 | 185671 | 0.21% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $745206 | 168218 | 0.19% | 股份 |
| Numerai GP LLC | $706430 | 159465 | 0.18% | 股份 |
| FRANKLIN RESOURCES INC | $691350 | 156061 | 0.18% | 股份 |
| RHUMBLINE ADVISERS | $678777 | 153225 | 0.17% | 股份 |
| CenterBook Partners LP | $660867 | 149180 | 0.17% | 股份 |
| Jump Financial, LLC | $656007 | 148083 | 0.17% | 股份 |
| XTX Topco Ltd | $632263 | 142723 | 0.16% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $616380 | 141048 | 0.16% | 股份 |
| JPMORGAN CHASE & CO | $615690 | 141864 | 0.16% | 股份 |
| Cubist Systematic Strategies, LLC | $542566 | 156359 | 0.14% | 股份 |
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×4 申报 | 2023年9月19日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 19 位内幕人士 · 10 位高管 · 11 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Wenbin Jiang | PRESIDENT AND CEO | 2026年8月18日 M | 5561029 | 0 | 0 | $0 |
| William D. Mccombe | Chief Financial Officer | 2026年8月18日 M | 134693 | 0 | 0 | $0 |
| Patrick Jeanmonod | CHIEF FINANCIAL OFFICER | 2024年3月11日 M | 97465 | 0 | 0 | $0 |
| Paul Christopher Williams | CHIEF OPERATING OFFICER | 2024年8月19日 M | 16473 | 0 | 0 | $0 |
| Ming Yan | CHIEF TECHNOLOGY OFFICER | 2026年8月18日 M | 4821870 | 0 | 0 | $0 |
| Ilan Feuchtwang | Chief Legal Officer, Secretary | 2026年8月10日 A | · | 0 | 0 | $0 |
| Philippe Busque | SVP, GLOBAL SALES AND SERVICES | 2026年5月18日 M | 43466 | 0 | 0 | $0 |
| Valerie Barnett | CHIEF LEGAL OFFICER | 2026年5月18日 M | 150012 | 0 | 0 | $0 |
| Allen Poirson | SVP BUS. AND CORP. DEV. | 2024年11月18日 M | 59981 | 0 | 0 | $0 |
| Jonathan Todd Garland | Chief Commercial Officer | 2023年8月18日 M | 8763 | 0 | 0 | $0 |
| Michael Holder | 董事 | 2026年8月18日 M | 62875 | 0 | 0 | $0 |
| Richard Chin | 董事 | 2026年8月18日 M | 28499 | 0 | 0 | $0 |
| Glenn P Muir | 董事 | 2026年8月18日 M | 3086 | 0 | 0 | $0 |
| Vera Imper | 董事 | 2026年6月10日 M | 59679 | 0 | 0 | $0 |
| Jack Ball | 董事 | 2026年6月10日 M | 86678 | 0 | 0 | $0 |
| Deborah J Neff | 董事 | 2026年6月10日 M | 59679 | 0 | 0 | $0 |
| Don M Hardison | 董事 | 2025年6月5日 M | 15706 | 0 | 0 | $0 |
| Gisele Dion | 董事 | 2023年6月14日 A | 5000 | 0 | 0 | $0 |
| Feng Deng | 董事 | 2021年7月22日 C | 443800 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 21 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IBB · iShares Trust | 0.04% | 911338 SH | 2026年9月11日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.03% | 106025 SH | 2026年8月19日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.03% | 121651 SH | 2026年10月2日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.02% | 700141 SH | 2026年8月19日 | 每日 |
| IWM · iShares Trust | 0.02% | 3106810 SH | 2026年9月11日 | 每日 |
| RSSL · Global X Funds | 0.02% | 58111 NS | 2026年7月31日 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 1299836 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.01% | 325613 SH | 2026年8月19日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.01% | 292301 NS | 2026年7月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 372840 NS | 2026年7月31日 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 3616 NS | 2026年7月31日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 10300 NS | 2026年7月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 12189 NS | 2026年7月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 26782 NS | 2026年7月31日 | N-PORT |
| DFSV · Dimensional ETF Trust | 0.00% | 18244 NS | 2026年7月31日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 119354 SH | 2026年9月11日 | 每日 |
| IWV · iShares Trust | 0.00% | 28666 SH | 2026年9月11日 | 每日 |
| DFUS · Dimensional ETF Trust | 0.00% | 30693 NS | 2026年7月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 3525848 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 9813 SH | 2026年8月19日 | 每日 |
| IWN · iShares Trust | · | 1134041 SH | 2026年9月11日 | 每日 |
CTKB 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 10 位分析师
买入
中位数目标
$5.00
-14.8%
3 30.0%
强烈买入
4 40.0%
买入
3 30.0%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
4 位分析师 · 2026-09-29平均目标 $5.56 -5.2%
现在
当前价格 $5.87
最低$4.75
平均值$5.56
最高$7.50
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| CTKB | $649M | 505.0 | 0.52% | -33.0% | -18.5% | 51.8% |
| AZTA | $1.32B | -23.5 | 3.5% | -9.4% | -3.3% | 45.5% |
| PSNL | $816M | -8.7 | -17.7% | -116.7% | -36.0% | · |
| CYRX | $479M | 6.9 | 12.4% | 44.4% | 15.3% | 47.1% |
| DNA | $484M | -1.5 | -25.1% | -183.8% | -55.8% | · |
| PACB | $565M | -1.0 | 3.9% | -341.5% | -1634.9% | 28.6% |
| MLAB | $489M | 73.1 | 3.4% | 2.7% | 3.7% | 63.5% |
| OABI | · | · | · | · | · | · |
| TKNO | $204M | -11.9 | 7.3% | -42.6% | -23.8% | 33.2% |
| QSI | · | · | · | · | · | · |
| LAB | $495M | -6.4 | -6.2% | -87.8% | -17.6% | 49.9% |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 5, 2026 申报